Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,477 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
Ota H, Nagano H, Sakon M, Eguchi H, Kondo M, Yamamoto T, Nakamura M, Damdinsuren B, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Wakasa K, Monden M. Ota H, et al. Among authors: nagano h. Br J Cancer. 2005 Sep 5;93(5):557-64. doi: 10.1038/sj.bjc.6602742. Br J Cancer. 2005. PMID: 16106266 Free PMC article.
Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
Noda T, Nagano H, Takemasa I, Yoshioka S, Murakami M, Wada H, Kobayashi S, Marubashi S, Takeda Y, Dono K, Umeshita K, Matsuura N, Matsubara K, Doki Y, Mori M, Monden M. Noda T, et al. Among authors: nagano h. Br J Cancer. 2009 May 19;100(10):1647-58. doi: 10.1038/sj.bjc.6605064. Epub 2009 Apr 28. Br J Cancer. 2009. PMID: 19401692 Free PMC article.
Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
Tomimaru Y, Eguchi H, Wada H, Noda T, Murakami M, Kobayashi S, Marubashi S, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Tomimaru Y, et al. Among authors: nagano h. Br J Cancer. 2010 May 11;102(10):1483-90. doi: 10.1038/sj.bjc.6605669. Epub 2010 Apr 20. Br J Cancer. 2010. PMID: 20407444 Free PMC article.
miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.
Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, Wada H, Kawamoto K, Kobayashi S, Tomokuni A, Tomimaru Y, Mori M, Doki Y. Iwagami Y, et al. Among authors: nagano h. Br J Cancer. 2013 Jul 23;109(2):502-11. doi: 10.1038/bjc.2013.320. Epub 2013 Jun 25. Br J Cancer. 2013. PMID: 23799850 Free PMC article.
MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.
Hasegawa S, Eguchi H, Nagano H, Konno M, Tomimaru Y, Wada H, Hama N, Kawamoto K, Kobayashi S, Nishida N, Koseki J, Nishimura T, Gotoh N, Ohno S, Yabuta N, Nojima H, Mori M, Doki Y, Ishii H. Hasegawa S, et al. Among authors: nagano h. Br J Cancer. 2014 Oct 14;111(8):1572-80. doi: 10.1038/bjc.2014.454. Epub 2014 Aug 12. Br J Cancer. 2014. PMID: 25117811 Free PMC article.
[A case report of hepatocellular carcinoma with hepatic and portal venous tumor thrombus and multiple intrahepatic metastasis who survived over 1 year after the operation with combined locoregional chemotherapy].
Shimizu J, Nagano H, Sakon M, Dono K, Takeda Y, Kishimoto S, Eguchi H, Miyamoto A, Kondo M, Nakamori S, Umeshita K, Nakamura H, Wakasa K, Monden M. Shimizu J, et al. Among authors: nagano h. Gan To Kagaku Ryoho. 1999 Oct;26(12):1895-9. Gan To Kagaku Ryoho. 1999. PMID: 10560420 Japanese.
1,477 results